The Food and Drug Administration plans on expediting CBD rules and regulations, potentially by the end of summer or early fall.

The previous update provided by the agency last month offered no insight into the FDA’s plans to regulate the cannabinoid but said they would apply a “rigorous and science-based approach” in crafting the rules and regulations.

See the original article at Ganjapreneur